OncLive
23.6K subscribers
1:58
ASCO 2024 Applications in Gynecologic Oncology: Episode 4
OncLive
34 views • 2 days ago
2:30
Dr Andre on the Efficacy of Nivolumab/Ipilimumab in MSI-H/dMMR mCRC Subgroups
OncLive
73 views • 3 days ago
2:05
Dr Choueiri on Lessons Learned from the TiNivo-2 Study in Metastatic RCC
OncLive
57 views • 5 days ago
0:59
Dr Secord on Mirvetuximab Soravtansine in Platinum-Sensitive, FRα-High Ovarian Cancer
OncLive
57 views • 5 days ago
1:05
Dr Lin on the Efficacy of T-DXd in HER2+ Advanced Breast Cancer With CNS Metastases
OncLive
74 views • 6 days ago
1:36
Dr Girard on Nivolumab Plus Relatlimab and Chemotherapy in Stage IV or Recurrent NSCLC
OncLive
51 views • 6 days ago
0:59
Dr Wilky on a Study of Botensilimab Plus Balstilimab in Refractory Metastatic Sarcoma
OncLive
43 views • 7 days ago
1:04
Dr Jonasch on the Preliminary Efficacy of NKT-2152 in Advanced ccRCC
OncLive
53 views • 7 days ago
2:35
Dr Eads on the Rationale for ECOG-ACRIN EA2174 in Esophageal/GEJ Adenocarcinoma
OncLive
52 views • 8 days ago
2:59
Dr Chalasani on the Potential Utility of Eftilagimod Alpha in HER2–/HER2-Low Breast Cancer
OncLive
49 views • 8 days ago
1:55
Dr Danilov on Ongoing MCL Clinical Trials
OncLive
83 views • 8 days ago
1:34
ASCO 2024 Applications in Gynecologic Oncology: Episode 3
OncLive
34 views • 9 days ago
2:18
Dr Heymach on Updated AEGEAN Data in Resectable NSCLC
OncLive
54 views • 10 days ago
3:13
Dr Rosca on Key Challenges in Genetic Testing for Lung Cancer
OncLive
86 views • 11 days ago
2:44
Dr Borczuk on Currently Offered Gene Testing for Patients With Lung Cancer
OncLive
85 views • 11 days ago
0:59
Dr Nowakowski on the Current Treatment Landscape for DLBCL
OncLive
50 views • 13 days ago
1:26
Dr McGregor on the Updated NCCN Guidelines for Non–Clear Cell RCC
OncLive
40 views • 13 days ago
4:40
Dr Ornstein on the Use of IO/TKI Doublets in Non-ccRCC
OncLive
26 views • 13 days ago
1:05
Dr Seymour on the Role of Mutational Profiling in CLL
OncLive
27 views • 13 days ago
1:21
Dr Koff on the Role of Covalent BTK Inhibitors and Pirtobrutinib in MCL
OncLive
28 views • 2 weeks ago
2:02
ASCO 2024 Applications in Gynecologic Oncology: Episode 2
OncLive
25 views • 2 weeks ago
1:35
Dr Sabari on the FDA Approval of Amivantamab/Lazertinib in EGFR+ Advanced NSCLC
OncLive
83 views • 2 weeks ago
1:12
Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advanced/Recurrent Endometrial Cancer
OncLive
68 views • 2 weeks ago
1:24
Dr Nagpal on the FDA Approval of Vorasidenib for Grade 2 Astrocytoma or Oligodendroglioma
OncLive
102 views • 2 weeks ago
1:53
Dr Daver on the Potential Utility of Uproleselan in R/R AML
OncLive
53 views • 2 weeks ago
3:04
Dr Grunwald on the Patient Population and Limitations of the REVEAL Study in PV
OncLive
42 views • 2 weeks ago
2:30
Dr Nowakowski on the EPCORE NHL-1 Trial Results of Epcoritamab in R/R Follicular Lymphoma
OncLive
38 views • 2 weeks ago
1:32
Dr Chase on the FDA Approval of Dostarlimab Plus Chemotherapy in Endometrial Cancer
OncLive
115 views • 2 weeks ago
1:40
Dr McCarthy on Neutrophil Activity in Multiple Myeloma
OncLive
41 views • 2 weeks ago
2:02
Dr Li on Cretostimogene Grenadenorepvec Plus Pembrolizumab in BCG-Unresponsive NMIBC
OncLive
167 views • 3 weeks ago
Load More